Breast cancers are categorized into subtypes based on hormone receptors (HR), namely estrogen receptor (ER) and progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression status. This evidence concerns the gene ERBB2 and breast cancer.